Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-20-003580
Filing Date
2020-06-26
Accepted
2020-06-26 13:15:30
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ewlu_10q.htm 10-Q 390786
2 CERTIFICATION ewlu_ex311.htm EX-31.1 9259
3 CERTIFICATION ewlu_ex321.htm EX-32.1 2861
  Complete submission text file 0001477932-20-003580.txt   2770260

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ewlu-20200331.xml EX-101.INS 411912
5 XBRL TAXONOMY EXTENSION SCHEMA ewlu-20200331.xsd EX-101.SCH 43389
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ewlu-20200331_lab.xml EX-101.LAB 271814
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ewlu-20200331_cal.xml EX-101.CAL 47369
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ewlu-20200331_pre.xml EX-101.PRE 222592
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ewlu-20200331_def.xml EX-101.DEF 113323
Mailing Address 100 N. BARRANCA ST. #1000 WEST COVINA CA 91791
Business Address 100 N. BARRANCA ST. #1000 WEST COVINA CA 91791 626-331-7570
Merion, Inc. (Filer) CIK: 0001517498 (see all company filings)

EIN.: 452898504 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-173681 | Film No.: 20992750
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries